FR2423219B1 - - Google Patents

Info

Publication number
FR2423219B1
FR2423219B1 FR7836690A FR7836690A FR2423219B1 FR 2423219 B1 FR2423219 B1 FR 2423219B1 FR 7836690 A FR7836690 A FR 7836690A FR 7836690 A FR7836690 A FR 7836690A FR 2423219 B1 FR2423219 B1 FR 2423219B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7836690A
Other versions
FR2423219A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AT511176A external-priority patent/AT352881B/de
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2423219A1 publication Critical patent/FR2423219A1/fr
Application granted granted Critical
Publication of FR2423219B1 publication Critical patent/FR2423219B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
FR7836690A 1976-07-12 1978-12-28 Solutions injectables a base aqueuse contenant au moins un derive de vitamine k Granted FR2423219A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT511176A AT352881B (de) 1976-07-12 1976-07-12 Verfahren zur herstellung von injektions- loesungen
CH699477A CH628811A5 (en) 1976-07-12 1977-06-07 Injection solutions

Publications (2)

Publication Number Publication Date
FR2423219A1 FR2423219A1 (fr) 1979-11-16
FR2423219B1 true FR2423219B1 (fr) 1980-10-24

Family

ID=25601846

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7720957A Granted FR2358161A1 (fr) 1976-07-12 1977-07-07 Solutions injectables a base aqueuse
FR7836690A Granted FR2423219A1 (fr) 1976-07-12 1978-12-28 Solutions injectables a base aqueuse contenant au moins un derive de vitamine k

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR7720957A Granted FR2358161A1 (fr) 1976-07-12 1977-07-07 Solutions injectables a base aqueuse

Country Status (18)

Country Link
US (1) US4158707A (fr)
JP (1) JPS6051448B2 (fr)
AU (1) AU517249B2 (fr)
CA (1) CA1082596A (fr)
DE (1) DE2730570A1 (fr)
DK (1) DK149483C (fr)
FR (2) FR2358161A1 (fr)
GB (1) GB1587076A (fr)
HK (1) HK26584A (fr)
IE (1) IE46037B1 (fr)
IL (1) IL52458A (fr)
IT (1) IT1202370B (fr)
LU (2) LU77708A1 (fr)
MY (1) MY8500263A (fr)
NL (1) NL189072C (fr)
NZ (1) NZ184564A (fr)
PH (1) PH16333A (fr)
SE (1) SE448516B (fr)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2914788A1 (de) * 1979-04-11 1980-10-16 Nattermann A & Cie Parenteral applizierbare, stabile arzneimittelloesungen mit entzuendungshemmender wirkung
CA1173360A (fr) * 1979-06-22 1984-08-28 Jurg Schrank Produits pharmaceutiques
US4264583A (en) * 1979-07-25 1981-04-28 The Procter & Gamble Company Gallstone dissolution compositions and method
JPS57163313A (en) * 1981-03-31 1982-10-07 Nippon Shinyaku Co Ltd Vitamin e pharmaceutical and its preparation
JPH0768117B2 (ja) * 1983-05-06 1995-07-26 ベスター・インコーポレイテツド 薬剤放出調整用小胞製剤
IL72420A (en) * 1983-07-22 1987-10-30 Hoffmann La Roche Aqueous vitamin e solutions and their manufacture
JPH0818989B2 (ja) * 1984-01-12 1996-02-28 株式会社ミドリ十字 脂肪乳剤中のプロスタグランジンの安定化方法
CA1264162A (fr) * 1984-03-15 1990-01-02 Manfred Breuninger Glycero-oxy-phosphatides
US5002936A (en) * 1985-04-12 1991-03-26 Seymour Lieberman Lipophilic complexes of pharmacologically active inorganic mineral acid esters of organic compounds
US4831018A (en) * 1985-05-17 1989-05-16 Smithkline Beckman Corporation Polyene antibiotic emulsion formulation
HU197212B (en) * 1985-08-02 1989-03-28 Merz & Co Gmbh & Co Process for producing pharmaceuticals with antiviral and antitumour effect
US5023271A (en) * 1985-08-13 1991-06-11 California Biotechnology Inc. Pharmaceutical microemulsions
SE8505047L (sv) * 1985-10-25 1987-04-26 Nutritional Int Res Inst Fettemulsion
CA1319886C (fr) * 1987-02-03 1993-07-06 Alberto Ferro Solutions de micelles mixtes
DE3903753A1 (de) * 1989-02-06 1990-08-23 Schering Ag Verfahren zur herstellung waessriger mischmicelloesungen
NZ232865A (en) * 1989-03-21 1992-07-28 Hoffmann La Roche A mixed-micelle solution comprising a micelle former and an immunomodulator
US5085864A (en) * 1989-10-30 1992-02-04 Abbott Laboratories Injectable formulation for lipophilic drugs
DE3938030A1 (de) * 1989-11-13 1991-05-16 Schering Ag Verfahren zur herstellung waessriger mischmicelloesungen
CA2033725C (fr) * 1990-01-24 2001-05-29 Folker Pittrof Compositions pharmaceutiques et cosmetiques
CA2033714A1 (fr) * 1990-01-25 1991-07-26 Alberto Ferro Preparations pharmaceutiques
FR2663224B1 (fr) * 1990-06-14 1995-01-20 Applicationes Farmaceuticas Sa Forme galenique parenterale.
DE4122661C2 (de) * 1990-08-06 1996-07-11 Nattermann A & Cie Pharmazeutisches Produkt zur Behandlung von Pneumocystis-carinii-Pneumonie
ZA916314B (en) * 1990-08-17 1992-05-27 Hoffmann La Roche Use of mixed micelles
AU663309C (en) * 1991-02-08 2002-08-08 Pro-Neuron, Inc. Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
DE4336434A1 (de) * 1993-10-26 1995-04-27 Hoechst Ag Pharmazeutische Zubereitung für die parenterale, enterale und dermale Verabreichung von praktisch unlöslichen Arzneistoffen und Verfahren zu ihrer Herstellung
ES2206473T3 (es) * 1994-05-20 2004-05-16 Gesellschaft Fur Medizinische Forschung Und Weiterbildung E.V. Gmf Emulsion de aceite en agua que contiene lormetazepam.
GB9426104D0 (en) * 1994-12-23 1995-02-22 Merck Sharp & Dohme Use of surfactants and emulsions
JP2740153B2 (ja) * 1995-03-07 1998-04-15 エフ・ホフマン−ラ ロシユ アーゲー 混合ミセル
US5759445A (en) * 1995-05-24 1998-06-02 Matsushita Electric Industrial Co., Ltd. Lipid-dispersed solution and process for producing the same
GB2326337A (en) * 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
US6350738B1 (en) 1998-03-06 2002-02-26 Brigham Young University Steroid derived antibiotics
US6767904B2 (en) * 1998-03-06 2004-07-27 Bringham Young University Steroid derived antibiotics
JP2004524368A (ja) * 2001-03-27 2004-08-12 フェアーズ ファーマシューティカル リサーチ エヌ．ヴェー． 低い水溶性を有する生物学的に活性な化合物を可溶化するための方法および組成物
EP1730516A1 (fr) * 2004-03-30 2006-12-13 Pfizer Products Incorporated Procede et dispositif pour l'evaluation de compositions pharmaceutiques
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
PL2422789T3 (pl) * 2004-05-19 2018-09-28 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Wstrzykiwalna kompozycja zawierająca deoksycholan sodu
WO2008065502A1 (fr) * 2006-11-29 2008-06-05 Pfizer Products Inc. Compositions pharmaceutiques constituées a) de nanoparticules comprenant des polymères entériques et b) de la caséine
US20100119612A1 (en) * 2007-04-17 2010-05-13 Bend Research, Inc Nanoparticles comprising non-crystalline drug
WO2008135855A2 (fr) * 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticules contenant un inhibiteur de la protéine de transfert d'ester de cholestéryle et un polymère non ionisable
US20100080852A1 (en) * 2007-05-03 2010-04-01 Ronald Arthur Beyerinck Phamaceutical composition comprising nanoparticles and casein
US8309129B2 (en) * 2007-05-03 2012-11-13 Bend Research, Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
US9545384B2 (en) 2007-06-04 2017-01-17 Bend Research, Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate
EP2162120B1 (fr) * 2007-06-04 2016-05-04 Bend Research, Inc Nanoparticules comportant un polymère cellulosique non ionisable et un copolymère bloc amphiphile non ionisable
US20100215747A1 (en) * 2007-07-13 2010-08-26 Corey Jay Bloom Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers
WO2009073216A1 (fr) * 2007-12-06 2009-06-11 Bend Research, Inc. Nanoparticules comprenant un polymère non ionisable et un copolymère de méthacrylate fonctionnalisé par amine
WO2009073215A1 (fr) * 2007-12-06 2009-06-11 Bend Research, Inc. Compositions pharmaceutiques comprenant des nanoparticules et une matière de remise en suspension
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
CN102058528B (zh) * 2009-11-13 2012-12-12 中国科学院上海药物研究所 一种黄豆苷元胶束及其制备方法
GB2480632A (en) 2010-05-25 2011-11-30 Kythera Biopharmaceuticals Inc Preparation of 12-keto and 12-alpha-hydroxy steroids
CA2827643C (fr) 2011-02-18 2019-05-07 Kythera Biopharmaceuticals, Inc. Traitement de graisse sous-mentale
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
WO2013180253A1 (fr) * 2012-05-31 2013-12-05 テルモ株式会社 SUPPORT SENSIBLE AU pH ET PROCÉDÉ POUR LE PRODUIRE, MÉDICAMENT SENSIBLE AU pH ET COMPOSITION PHARMACEUTIQUE SENSIBLE AU pH CONTENANT CHACUN LEDIT SUPPORT, ET PROCÉDÉ DE CULTURE EMPLOYANT LEDIT MÉDICAMENT SENSIBLE AU pH OU LADITE COMPOSITION PHARMACEUTIQUE SENSIBLE AU pH
US9321749B1 (en) 2012-07-25 2016-04-26 Globavir Biosciences, Inc. Heterocyclic compounds and uses thereof
JP6154025B2 (ja) 2012-12-24 2017-06-28 ニューロガストルクス，インコーポレイテッド Ｇｉ管障害を治療するための方法
WO2015200369A1 (fr) 2014-06-24 2015-12-30 Neurogastrx, Inc. Promédicaments de métopimazine
CN110876719B (zh) * 2018-09-06 2022-08-09 中国人民解放军军事科学院军事医学研究院 一种维生素k1注射剂及其制备方法
US10836757B1 (en) 2020-04-02 2020-11-17 Neurogastrx, Inc. Polymorphic forms of metopimazine

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE575616C (de) * 1928-12-14 1933-04-29 Hans Much Dr Verfahren zur Herstellung bestaendiger, klarer, waessriger Loesungen von Lipoiden, Fetten oder Harzen
DE932083C (de) * 1954-03-31 1955-08-22 Upha Chem Pharm Praeparate G M Verfahren zur Herstellung stabiler waessriger Injektionsloesungen von 2-Methyl-5, 8-dimethoxy-furanochromon
US3044931A (en) * 1960-01-27 1962-07-17 Geigy Chem Corp Aryloxy acetic acid amides: process for parenteral application
NL260444A (fr) * 1960-12-05
US3639597A (en) * 1968-02-02 1972-02-01 Merck & Co Inc Pharmaceutical compositions containing cholanic acid conjugates
GB1317184A (en) * 1969-06-20 1973-05-16 Glaxo Lab Ltd Steroid-containing pharmaceutical preparations
US3900561A (en) * 1970-12-17 1975-08-19 Glaxo Lab Ltd Pharmaceutical compositions
US3917830A (en) * 1970-12-17 1975-11-04 Glaxo Lab Ltd Steroidal anaesthetic composition for intraveneous injection
US4017616A (en) * 1972-01-21 1977-04-12 American Home Products Corporation Parenteral benzodiazepine compositions
AU461715B2 (en) * 1972-01-21 1975-05-19 American Home Products Corporation Parenteral benzodiazepine compositions
DE2315609A1 (de) * 1973-03-29 1974-10-17 Holzhueter Hermann Verfahren zum loesen von indomethacin in wasser und eine indomethacin enthaltende pharmazeutische zubereitung zur parenteralen applikation
DE2433173C3 (de) * 1974-07-10 1980-02-07 J. Pfrimmer & Co, 8520 Erlangen Verwendung von Cholansaurederivaten

Also Published As

Publication number Publication date
DE2730570A1 (de) 1978-01-19
AU2684677A (en) 1979-01-11
NL189072C (nl) 1993-01-04
DK149483B (da) 1986-06-30
LU90037I2 (fr) 1997-06-13
GB1587076A (en) 1981-03-25
JPS539314A (en) 1978-01-27
FR2358161B1 (fr) 1980-07-25
DE2730570C2 (fr) 1989-01-19
NL7707641A (nl) 1978-01-16
MY8500263A (en) 1985-12-31
NZ184564A (en) 1979-12-11
IL52458A0 (en) 1977-10-31
US4158707A (en) 1979-06-19
FR2423219A1 (fr) 1979-11-16
FR2358161A1 (fr) 1978-02-10
PH16333A (en) 1983-09-05
JPS6051448B2 (ja) 1985-11-14
IE46037B1 (en) 1983-02-09
NL189072B (nl) 1992-08-03
IE771403L (en) 1978-01-12
DK149483C (da) 1986-12-15
HK26584A (en) 1984-03-30
SE7708059L (sv) 1978-01-13
AU517249B2 (en) 1981-07-16
IT1202370B (it) 1989-02-09
CA1082596A (fr) 1980-07-29
IL52458A (en) 1980-10-26
SE448516B (sv) 1987-03-02
LU77708A1 (fr) 1978-09-14
DK314777A (da) 1978-01-13

Similar Documents

Publication Publication Date Title
DE2711234C3 (fr)
DE2745932C3 (fr)
FR2358161B1 (fr)
FI772410A (fr)
DE2736502C2 (fr)
DE2652133C2 (fr)
DK257676A (fr)
DE2725714C2 (fr)
DK88977A (fr)
DK261077A (fr)
FR2343244B1 (fr)
DK142767C (fr)
DE2746135C2 (fr)
JPS52145915U (fr)
DK432776A (fr)
DK48176A (fr)
JPS5328097U (fr)
DK142780C (fr)
JPS5746212Y2 (fr)
DK391376A (fr)
FI52921B (fr)
JPS5419998Y2 (fr)
JPS5713663Y2 (fr)
JPS5313840U (fr)
JPS5312327U (fr)

Legal Events

Date Code Title Description
TP Transmission of property
CC Supplementary protection certificate (spc) laid open to the public (law of 25 june 1990)

Free format text: 92C0120, 920430

CB Supplementary protection certificate (spc) granted (law of 25 june 1990)

Free format text: 92C0120, 781228

CL Concession to grant licences